Diseases, Conditions, Syndromes

China reports zero local virus cases as Delta outbreak retreats

China reported no new domestic coronavirus cases Monday, and Beijing appears poised to bring to heel the pandemic's most serious resurgence in months—driven by the highly contagious Delta variant—with mass testing and ...

Medical research

Continuous biomarker monitoring for personalised medicine

Similar to blood sugar, various biomarkers could in future be identified using just a few drops of blood. Researchers at Ruhr-Universität Bochum are developing a multi-analyte test strip for this purpose that will open up ...

Diseases, Conditions, Syndromes

Can contact tracing apps save us from COVID-19?

Associate Professor in Health and Medical Geography at the University of Canterbury, Dr. Malcolm Campbell says that relying on smartphone-based approaches involves some big assumptions and we need to carefully consider what ...

Medical research

Personalizing drug development using big data

A new computer program developed at the University of Arizona College of Medicine—Tucson and recently licensed to startup INTelico Therapeutics, LLC, is pushing the envelope of precision medicine. By integrating the genetic ...

Other

The 'AI turn' for digital health: A futuristic view

The unprecedented implications of digital health innovations, being co-produced by the mainstreaming and integration of artificial intelligence (AI), the Internet of Things (IoT), and cyber-physical systems (CPS) in healthcare, ...

Oncology & Cancer

Entrectinib gets edge over crizotinib against ROS1+ lung cancer

Crizotinib and entrectinib are both active against ROS1+ non-small cell lung cancer. But which is best? The answer seems easy: Just compare the drugs' clinical trial results. However, not all trials are created equal, and ...

page 21 from 24